bpc-157 clinical trials recruiting Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Applications, and Future Perspectives The Stable Gastric Pentadecapeptide BPC
Description
The First Human Data: OvationLabs Oral Evaluation In 2024, OvationLab completed the first human evaluation of oral BPC-157an open-label pragmatic study with results detailed publicly in 2025
Including all doses in the charts above would have made them unreadable so we eliminated similar dose-responses
2mg semaglutide vial The 2mg vial is the smallest commonly available size
Color does not affect the safety or effectiveness of the product
